by NAVIGO USER_1 | May 11, 2021 | Press
Solid tumor-specific scaffold protein ligands from Navigo combined with MDimune’s BioDrone® technology to create novel targeted extracellular vesicle-based therapeutics Halle/Saale, Germany and Seoul, Korea, May 11th, 2021. Navigo Proteins, a protein engineering...
by NAVIGO USER_1 | Mar 16, 2021 | Press
Custom Affinity Chromatography Resin Promises High Yield Purification in Clinical and Commercial GMP Downstream Processing Halle/Saale, Germany and Freiburg, Germany, March 16th, 2021. Navigo Proteins GmbH (“Navigo”), a premier protein engineering company, developer...
Recent Comments